Risk adjusted net present value: What is the current valuation of Pfizer’s Ibuzatrelvir?
The revenue for Ibuzatrelvir is expected to reach an annual total of $21 mn by 2036 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that …